BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9031746)

  • 1. Activation and inhibition of rat neuronal nicotinic receptors by ABT-418.
    Papke RL; Thinschmidt JS; Moulton BA; Meyer EM; Poirier A
    Br J Pharmacol; 1997 Feb; 120(3):429-38. PubMed ID: 9031746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands.
    Briggs CA; McKenna DG; Piattoni-Kaplan M
    Neuropharmacology; 1995 Jun; 34(6):583-90. PubMed ID: 7566493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist and antagonist effects of nicotine on chick neuronal nicotinic receptors are defined by alpha and beta subunits.
    Hussy N; Ballivet M; Bertrand D
    J Neurophysiol; 1994 Sep; 72(3):1317-26. PubMed ID: 7807214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel Na(+)/Ca(2+) exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptors.
    Pintado AJ; Herrero CJ; García AG; Montiel C
    Br J Pharmacol; 2000 Aug; 130(8):1893-902. PubMed ID: 10952680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
    Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
    Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.
    Puttfarcken PS; Manelli AM; Arneric SP; Donnelly-Roberts DL
    J Neurochem; 1997 Sep; 69(3):930-8. PubMed ID: 9282914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.
    Olivera-Bravo S; Ivorra I; Morales A
    Br J Pharmacol; 2005 Jan; 144(1):88-97. PubMed ID: 15644872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
    Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP
    J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
    Sullivan JP; Donnelly-Roberts D; Briggs CA; Anderson DJ; Gopalakrishnan M; Xue IC; Piattoni-Kaplan M; Molinari E; Campbell JE; McKenna DG; Gunn DE; Lin NH; Ryther KB; He Y; Holladay MW; Wonnacott S; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1997 Oct; 283(1):235-46. PubMed ID: 9336329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 4-2 beta 2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs.
    Connolly J; Boulter J; Heinemann SF
    Br J Pharmacol; 1992 Mar; 105(3):657-66. PubMed ID: 1378342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ion channel properties of a rat recombinant neuronal nicotinic receptor are dependent on the host cell type.
    Lewis TM; Harkness PC; Sivilotti LG; Colquhoun D; Millar NS
    J Physiol; 1997 Dec; 505 ( Pt 2)(Pt 2):299-306. PubMed ID: 9423173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
    Warpman U; Nordberg A
    Neuroreport; 1995 Nov; 6(17):2419-23. PubMed ID: 8747166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced inhibition of a mutant neuronal nicotinic acetylcholine receptor by agonists: protection of function by (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403).
    Papke RL
    J Pharmacol Exp Ther; 2002 May; 301(2):765-73. PubMed ID: 11961083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of function mutation of the alpha7 nicotinic receptor: distinct pharmacology of the human alpha7V274T variant.
    Briggs CA; McKenna DG; Monteggia LM; Touma E; Roch JM; Arneric SP; Gopalakrishnan M; Sullivan JP
    Eur J Pharmacol; 1999 Feb; 366(2-3):301-8. PubMed ID: 10082212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the alpha subunit on imidacloprid sensitivity of recombinant nicotinic acetylcholine receptors.
    Matsuda K; Buckingham SD; Freeman JC; Squire MD; Baylis HA; Sattelle DB
    Br J Pharmacol; 1998 Feb; 123(3):518-24. PubMed ID: 9504393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of mouse muscle nicotinic receptors by serotonergic compounds.
    García-Colunga J; Miledi R
    Exp Physiol; 1999 Sep; 84(5):847-64. PubMed ID: 10502654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.